DRDGOLD Limited (0ICU)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 24.08 |
|---|---|
| 52-week range | 19.50 – 39.36 |
| Return, 1 month / 3 months | −5.5% / +20.0% |
| Return, 1 year / 3 years | −3.4% / +182.1% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 53.4% |
| Worst drawdown (1 year) | -48.9% |
| Average daily value traded | 0.04M USD |
| Dividend yield | 0.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
DRDGOLD Limited is a South African gold producer that recovers gold from the retreatment of surface tailings and slimes left by earlier mining. Its operations, based around Johannesburg, process old mine dumps and waste material to extract residual gold, and the company also runs related tailings storage and rehabilitation work. Its customers are the international gold market, where the metal it produces is refined and traded, while its activities are rooted in the historic goldfields of Gauteng.
DRDGOLD Limited trades under the code 0ICU on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
DRDGOLD Limited (0ICU) trades on the London Exchange in UK. It last closed at USD 24.08 on 23 October 2026.
Its price-based Market X-Ray is 32 out of 100 (a weak price profile), ranking 3,021 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.4% and over the last three months it rose 20.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 27 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -10.7% | ||
| From 52-week high | -38.2% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 20.0% | ||
| 6-month return | -13.3% | ||
| 12-month return, skipping the last month | 2.1% | ||
| Stability (higher is calmer) | 23 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 53.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.9% | ||
| Liquidity | 22 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.04M USD | ||
| Zero-volume days | 1.7% | ||
| Income | 22 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.3% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.7% |
|---|---|
| 1 month | −5.5% |
| 3 months | +20.0% |
| 6 months | −13.3% |
| 1 year | −3.4% |
| 3 years | +182.1% |
| 5 years | +210.2% |
Signals
| 50-day / 200-day average | 26.02 / 26.96 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.89 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Sep 2026 | ZAR 0.7368 |
| 13 Mar 2026 | ZAR 0.2955 |
| 12 Sep 2025 | ZAR 0.2300 |
| 14 Mar 2025 | ZAR 0.1654 |
| 13 Sep 2024 | ZAR 0.1133 |
| 7 Mar 2024 | ZAR 0.1067 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.